Jamie Henshall is a Director of DMPK at Vertex Pharmaceuticals, where he leads ADME, bioanalysis, and biotransformation teams. He specializes in translating complex data to guide strategy for programs in immunology, CNS, and rare diseases, holding a Ph. D. from The University of Manchester.
There is no publicly available information about Jamies personal life or interests outside of his professional work.
His teams have played a key role in enabling multiple clinical candidates by resolving critical ADME and pharmacokinetic liabilities, directly influencing program trajectory.
Read the full overview →They don’t always try to control the conversation but neither do they like yielding it fully. They can be nudged to make faster decisions by offering what they value. They respond well to confident salespeople.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.